{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:39:42Z","timestamp":1785451182297,"version":"3.56.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/mbc.0000000000000417","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T01:52:56Z","timestamp":1452909176000},"page":"190-198","source":"Crossref","is-referenced-by-count":6,"title":["Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers"],"prefix":"10.1097","volume":"27","author":[{"given":"Fatina I.","family":"Fadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"Elshamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa M.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman H.","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solaf","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona H.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"El-Ahmady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210203","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1182\/blood-2006-06-028902","article-title":"The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene.","volume":"108","author":"Lazo-Langer","year":"2006","journal-title":"Blood"},{"key":"R2-15-20210203","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1081\/JDI-120004098","article-title":"Pec[Combining Caron]ovnik-Balon B. Homocysteine and vascular access thrombosis in hemodialysis patients.","volume":"24","author":"Hojs","year":"2002","journal-title":"Ren Fail"},{"key":"R3-15-20210203","first-page":"476","article-title":"The challenge of cardiovascular risk factors in end-stage renal disease.","volume":"16","author":"Covic","year":"2003","journal-title":"J Nephrol"},{"key":"R4-15-20210203","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.02950707","article-title":"Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative.","volume":"3","author":"Huijbregts","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-15-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1681\/ASN.V74523","article-title":"Hemodialysis vascular access morbidity.","volume":"7","author":"Feldman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R6-15-20210203","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MBC.0000000000000125","article-title":"Soluble adhesion molecules as markers of native arteriovenous fistulathrombosis in children on uremia.","volume":"25","author":"Fadel","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R8-15-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1160\/TH10-12-0785","article-title":"Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease.","volume":"106","author":"Darlington","year":"2011","journal-title":"Thromb Haemost"},{"key":"R9-15-20210203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/003655100750046440","article-title":"Activation of coagulation during treatment with haemodialysis.","volume":"60","author":"Bartels","year":"2000","journal-title":"Scand J Clin Lab Invest"},{"key":"R10-15-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/ndt\/16.5.987","article-title":"Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.","volume":"16","author":"Sagedal","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R11-15-20210203","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-3848(96)00145-4","article-title":"Hemostasis, platelet function and serotonin in acute and chronic renal failure.","volume":"83","author":"Malyszko","year":"1996","journal-title":"Thromb Res"},{"key":"R12-15-20210203","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/hrt.81.2.134","article-title":"Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.","volume":"81","author":"Al-Saady","year":"1999","journal-title":"Heart"},{"key":"R13-15-20210203","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5301\/IJAO.2011.6469","article-title":"Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis.","volume":"34","author":"Milburn","year":"2011","journal-title":"Int J Artif Organs"},{"key":"R14-15-20210203","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/ndt\/11.7.1299","article-title":"Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.","volume":"11","author":"Erdem","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R15-15-20210203","first-page":"152","article-title":"Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.","volume":"16","author":"Oda","year":"2000","journal-title":"Adv Perit Dial"},{"key":"R16-15-20210203","first-page":"R55","article-title":"Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.","volume":"12","author":"Kirmizis","year":"2006","journal-title":"Med Sci Monit"},{"key":"R17-15-20210203","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1525-139X.2003.16048.x","article-title":"Thrombosis in end-stage renal disease.","volume":"16","author":"Casserly","year":"2003","journal-title":"Semin Dial"},{"key":"R18-15-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.thromres.2006.03.011","article-title":"Excess soluble urokinasetype plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.","volume":"119","author":"Pawlak","year":"2007","journal-title":"Thromb Res"},{"key":"R19-15-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1744-9987.2008.00558.x","article-title":"Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.","volume":"12","author":"Salobir","year":"2008","journal-title":"Ther Apher Dial"},{"key":"R20-15-20210203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/112972980800900212","article-title":"Plasminogen activator inhibitor-1 activity and 4G5G polymorphism in hemodialysis.","volume":"9","author":"Trimarchi","year":"2008","journal-title":"J Vasc Access"},{"key":"R21-15-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2004.03.007","article-title":"Risk factors for thromboembolic events in renal failure.","volume":"101","author":"DElia","year":"2005","journal-title":"Int J Cardiol"},{"key":"R22-15-20210203","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.03860412","article-title":"Thrombophilia and arteriovenous fistula survival in ESRD.","volume":"8","author":"Salmela","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-15-20210203","first-page":"433","article-title":"Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.","volume":"47","author":"Arsov","year":"2006","journal-title":"Croat Med J"},{"key":"R24-15-20210203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11239-005-3550-4","article-title":"Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.","volume":"20","author":"Almawi","year":"2005","journal-title":"J Thromb Thrombolysis"},{"key":"R25-15-20210203","first-page":"428","article-title":"IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.","volume":"56","author":"Adler","year":"2001","journal-title":"Clin Nephrol"},{"key":"R26-15-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","article-title":"3rd, Suki WW. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.","volume":"26","author":"Prakash","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R27-15-20210203","first-page":"1194","article-title":"Are antiphospholipid antibodies clinically relevant in dialysis patients Nephrol Dial T","volume":"14","author":"Chew","year":"1992","journal-title":"ransplant"},{"key":"R28-15-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3346\/jkms.2008.23.1.89","article-title":"Intereukin-10 tumor necrosis factor- polymorphisms in vascular access failure in patients on hemodialysis: preliminary data in Korea.","volume":"23","author":"Sung","year":"2008","journal-title":"J Korean Med Sci"},{"key":"R29-15-20210203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1067\/mva.2002.122025","article-title":"Recommended standards for reports dealing with arteriovenous hemodialysis accesses.","volume":"35","author":"Sidawy","year":"2002","journal-title":"J Vasc Surg"},{"key":"R30-15-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000170265","article-title":"Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients.","volume":"14","author":"Haznedaroglu","year":"1996","journal-title":"Blood Purif"},{"key":"R31-15-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1751-553X.2011.01356.x","article-title":"Platelet activation, coagulation activation and C-reactive protein in simultaneous samples from the vascular access and peripheral veins of haemodialysis patients.","volume":"34","author":"Milburn","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"R33-15-20210203","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1055\/s-0038-1649831","article-title":"Fibrin D-dimer, haemostatic factors and peripheral arterial disease.","volume":"74","author":"Lee","year":"1995","journal-title":"Thromb Haemost"},{"key":"R34-15-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"R35-15-20210203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jcp.46.2.104","article-title":"Detection and importance of anticardiolipin antibodies.","volume":"46","author":"Khamashta","year":"1993","journal-title":"J Clin Pathol"},{"key":"R36-15-20210203","first-page":"314","article-title":"Prothrombin, factor-V Leiden, plasminogen activator inhibitor type 1 gene polymorphisms in hemodialysis patients withwithout arteriovenous fistula thrombosis.","volume":"2","author":"Emirogullari","year":"2010","journal-title":"Int J Nephrol Urol"},{"key":"R37-15-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-4679(01)00408-5","article-title":"Emergency department D-dimer testing.","volume":"21","author":"Sadosty","year":"2001","journal-title":"J Emerg Med"},{"key":"R38-15-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5301\/JN.2010.4926","article-title":"Effect of a single hemodialysis session on endothelial dysfunction.","volume":"24","author":"Errakonda","year":"2011","journal-title":"J Nephrol"},{"issue":"Suppl 2","key":"R39-15-20210203","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1177\/089686080702702s51","article-title":"Adipokines and gut hormones in end-stage renal disease.","volume":"27","author":"Mak","year":"2007","journal-title":"Perit Dial Int"},{"key":"R40-15-20210203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1081\/JDI-42806","article-title":"Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.","volume":"27","author":"Shu","year":"2005","journal-title":"Ren Fail"},{"key":"R41-15-20210203","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ndt\/gfh622","article-title":"Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.","volume":"20","author":"Bonomini","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R42-15-20210203","doi-asserted-by":"crossref","first-page":"e67799","DOI":"10.1371\/journal.pone.0067799","article-title":"Thrombin-antithrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.","volume":"8","author":"Milburn","year":"2013","journal-title":"PLoS One"},{"key":"R43-15-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.semnephrol.2004.06.004","article-title":"Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 12, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.","volume":"24","author":"Molino","year":"2004","journal-title":"Semin Nephrol"},{"key":"R44-15-20210203","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1681\/ASN.V1261255","article-title":"Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.","volume":"12","author":"Segarra","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R45-15-20210203","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1742-1241.2005.00493.x","article-title":"Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis.","volume":"59","author":"Chuang","year":"2005","journal-title":"Int J Clin Pract"},{"key":"R46-15-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1523-1755.1999.00258.x","article-title":"Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.","volume":"55","author":"Manns","year":"1999","journal-title":"Kidney Int"},{"key":"R47-15-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","article-title":"Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.","volume":"26","author":"Prakash","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R48-15-20210203","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","article-title":"Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease.","volume":"6","author":"Garcia-Martin","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"R49-15-20210203","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2004110999","article-title":"Thrombophilia and the risk for hemodialysis vascular access thrombosis.","volume":"16","author":"Knoll","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R50-15-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1024\/0301-1526\/a000245","article-title":"The influence of thrombophilic risk factors on vascular access survival in chronic dialysis patients in a retrospective evaluation.","volume":"42","author":"Klamroth","year":"2013","journal-title":"Vasa"},{"key":"R51-15-20210203","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1744-9987.2010.00848.x","article-title":"Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia.","volume":"15","author":"Fekih-Mrissa","year":"2011","journal-title":"Ther Apher Dial"},{"key":"R52-15-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.1087","article-title":"Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.","volume":"67","author":"Gurgey","year":"2001","journal-title":"Am J Hematol"},{"key":"R53-15-20210203","first-page":"314","article-title":"Prothrombin, factor-V Leiden, and plasminogen activator inhibitor type 1 gene polymorphisms in hemodialysis patients withwithout arteriovenous fistula thrombosis.","volume":"2","author":"Emirogullari","year":"2010","journal-title":"Int J Nephrol Urol"},{"key":"R54-15-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11255-007-9321-8","article-title":"The influence of atherosclerosis and plasma D-dimer concentration in patients with a functioning arteriovenous fistula for maintenance hemodialysis.","volume":"40","author":"Stolic","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"R55-15-20210203","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ahj.2003.07.015","article-title":"Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-ST-segment elevation myocardial infarction.","volume":"147","author":"Gyongyosi","year":"2004","journal-title":"Am Heart J"},{"key":"R56-15-20210203","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V781169","article-title":"Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.","volume":"7","author":"De Marchi","year":"1996","journal-title":"J Am Soc Nephrol"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T19:48:43Z","timestamp":1654112923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201603000-00015"}},"subtitle":["a prospective analysis"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000417","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}